strap line
case studies Case Studies

Over the last 8 years CSS Partners has raised over £90 million.

CHARLES STREET SECURITIES INC EARLY STAGE GROWTH COMPANY FINANCINGS

DATE DETAIL CAPITAL RAISED PRICE
Dec-02 EIS equity financing for a bio-pharmaceutical company conductng a Phase 1 clinical trial for a Staphyloccocal vaccine £1.6M £1.00
Jun-04 Follow-on financing. £770,000 raised in an EIS qualifying equity placement £0.77M £1.40
Mar-09 Follow on EIS Equity Funding £0.75M £2.00
Nov-04 Equity financing for early stage company with innovative device for the dental market £2.0M £0.48
Jul-06 Follow-on financing £1.2M 8% Conv Pref
Jan-08 Follow on equity financing £0.3M £0.12
Nov-04 Placing of 10 million shares for AIM listed Australian bio-pharma company £0.92M £0.10
Apr-05 Equity financing for Clinical Trials programme for anti-inflammatory drug £1.9M £0.60
Mar-07 Second round equity financing for continuing Clinical Trials programme for anti-inflammatory drug £1.6M £0.80
Oct-05 Equity financing for Clinical Trials programme for French / Israeli oncology company. £1.8M £1.30
Dec-08 Follow on financing – issue of Convertible Loan Notes £0.3M
May-06 Equity financing for Israeli radiotherapy oncology diagnostic tool £1.6M £0.65

BACKGROUND TO CHARLES STREET SECURITIES, INC
Charles Street Securities Europe LLP (CSS) (CSS) is a private investment management and investment banking firm. The firm specialises in the financing of early stage companies offering significant growth potential.

FINANCING
Financings are conducted either through an affiliated principal investment vehicle CSS Bridge Partners LP, which specialises in interim financing and bridge loans or through distributed equity placement with clients of CSS and CSS Partners, generally documented with a full prospectus.

CSS typically works with its corporate clients until an exit is achieved through a listing or a trade sale. Follow-on financing is provided where necessary.

August 2007